Visit our poster presentation to learn more about Foresight CLARITY™ MRD detection in early-stage breast cancer.
- P2-01-25: “Circulating tumor DNA clearance by neoadjuvant chemotherapy or breast surgery detected using an ultra-sensitive ctDNA MRD assay in early breast cancer”
- Presented by Dr. Luc Cabel, Memorial Sloan Kettering Cancer Center
- Poster Session 2: Wednesday, December 11, 2024, 5:30-7:00pm